Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • swiftbiosci
    Registered Vendor
    • Jan 2013
    • 4

    #1

    New ssDNA-capable bisulfite sequencing library prep kit: Early Access Program

    Swift Biosciences has developed what we believe is a best-in-class bisulfite sequencing library preparation kit. We have just opened the Early Access Program that offers an opportunity to evaluate the kit before it is officially launched to the general scientific community.

    This kit uses new technology with the following benefits:
    • Pre-library bisulfite conversion enabled by single-stranded capability results in superior library yield
    • Provides even coverage across a range of GC content
    • Reduced need for PCR - PCR-free for inputs ≥ 500 ng; 100 ng input enabled with 3 cycles of PCR; 10 ng enabled with 6 cycles
    • Compatible with WGBS, RRBS, NimbleGen SeqCap Epi capture, and bisulfite-converted DNA enriched by MeDIP, ChIP, or other methods


    We are seeking testers able to complete a timely evaluation of the kit and instruction manual. If you are interested, please reply to this post, email [email protected], or call Technical Support at 734-330-2568 x101 to discuss the next steps.
    Last edited by swiftbiosci; 05-14-2014, 10:52 AM.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...